Construction and characterization of an OHIO-1 β-lactamase bearing Met69Ile and Gly238Ser mutations

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 1940-1943

  Bonomo, Robert A ^a,d   Knox, James R ^b   Rudin, Susan D ^a   Shlaes, David M ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c PFIZER INC   (United States)

^d Geriatric CARE Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; SULBACTAM;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONFORMATIONAL TRANSITION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME CONFORMATION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030875916     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.1940     Document Type: Article

References (28)

1. Ambler, R. P., A. F. W. Coulson, J. M. Frere, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A Standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-272. (Letter.)
2. Blazquez, J., M. R. Baquero, R. Canton, I. Alos, and F. Baquero. 1993. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:2059-2063.
3. Bonomo, R. A., C. Currie-McCumber, and D. M. Shlaes. 1992. OHIO-1 β-lactamase resistant to mechanism-based inactivators. FEMS Microbiol. Lett. 92:79-82.
4. Bonomo, R. A., C. G. Dawes, J. R. Knox, and D. M. Shlaes. 1995. β-Lactamase mutations far from the active site influence inhibitor binding. Biochem. Biophys. Acta 1247:121-125.
5. Bonomo, R. A., C. G. Dawes, J. R. Knox, and D. M. Shlaes. 1995. Complementary roles of mutations at positions 69 and 242 in a class A β-lactamase. Biochem. Biophys. Acta 1247:113-120.
6. Bonomo, R. A., J. R. Knox, C. G. Dawes, and D. M. Shlaes. 1994. Clavulanic acid (Clav) resistant double mutants of OHIO-1, a class A β-lactamase, abstr. C97, p. 138. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Brun, T., J. Peduzzi, M. M. Canica, G. Paul, P. Nevot, M. Barthelemy, and R. Labia. 1994. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with decreased susceptibility to β-lactamase inhibitors. FEMS Microbiol. Lett. 120:111-117.
8. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 39:1211-1233.
9. Collatz, E., R. Labia, and L. Gutmann. 1990. Molecular evolution of ubiquitous β-lactamases towards extended-spectrum enzymes active against newer β-lactam antibiotics. Mol. Microbiol. 4:1615-1620.
10. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430.
11. Huletsky, A., J. R. Knox, and R. C. Levesque. 1993. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type β-lactamases probed by site-directed mutagenesis and three-dimensional modeling. J. Biol. Chem. 268:3690-3697.
12. Imtiaz, U., E. Billings, J. R. Knox, E. K. Manavathu, S. A. Lerner, and S. Mobashery. 1993. Inactivation of class A β-lactamases by clavulanic acid: the role of arginine-244 in a proposed nonconcerted sequence of events. J. Am. Chem. Soc. 115:4435-4442.
13. Imtiaz, U., E. M. Billings, J. R. Knox, and S. Mobashery. 1994. A structure-based analysis of the inhibition of class A β-lactamases by sulbactam. Biochemistry 33:5728-5738.
14. Knox, J. R. 1993. Crystallography of penicillin-building enzymes, p. 36-49. In P. H. Bentley and R. Pondsford (ed.), Recent advances in the chemistry of anti-infective agents. Special Publication 119. Royal Society of Chemistry, London, United Kingdom.
15. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
16. Kunkel, T. A., J. D. Roberts, and R. A. Zkour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
17. Matagne, A., and J. M. Frere. 1995. Contribution of mutant analysis to the understanding of enzyme catalysis: the case of class A β-lactamases. Biochem. Biophys. Acta 1247:109-127.
18. McClary, J. A., F. Whitney, and J. Geisselsoder. 1989. Efficient site-directed in vitro mutagenesis using phagemid vectors. BioTechniques 7:282-287.
19. Raquet, X., J. Lamotte-Brasseur, E. Fonze, S. Goussard, P. Courvalin, and J. M. Frere. 1994. TEM β-lactamase mutants hydrolyzing third-generation cephalosporins. A kinetic and molecular modelling analysis. J. Mol. Biol. 244:625-639.
20. Saves, I., D. Burlet-Schiltz, P. Swaren, F. Lefevre, J.-M. Masson, J.-C. Prome, and J. P. Samama. 1995. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the β-lactamase resistance to clavulanic acid. J. Biol. Chem. 31:18240-18245.
21. Shlaes, D. M., and C. Currie-McCumber. 1992. Mutations altering substrate specificity in OHIO-1, an SHV-1 family β-lactamase. Biochem. J. 284:411-415.
22. Shlaes, D. M., C. Currie-McCumber, A. Hull, I. Behlau, and M. Kron. 1990. OHIO-1 β-lactamase is part of the SHV-1 family. Antimicrob. Agents Chemother. 34:1570-1576.
23. Stapleton, P., P.-J. Wu, A. King, K. Shannon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2478-2483.
24. Thomson, C. J., and S. G. B. Amyes. 1992. TRC-1: emergence of a clavulanic acid-resistant TEM-β-lactamase in a clinical strain. FEMS Microbiol. Lett. 70:113-117.
25. Vedel, G., A. Belaaouaj, L. Gilly, R. Labia, A. Phillipon, P. Nevot, and G. Paul. 1992. Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors. J. Antimicrob. Chemother. 30:449-462.
26. Venkatachalam, K. V., W. Huang, M. LaRocco, and T. Palzkill. 1994. Characterization of TEM-1 β-lactamase mutants from positions 238 and 241 with increased catalytic efficiency for ceftazidime. J. Biol. Chem. 269:23444-23450.
27. Zafaralla, G., S. Manavathu, S. A. Lerner, and S. Mobashery. 1992. Elucidation of the role of arginine-244 in the turnover processes of class A β-lactamases. Biochemistry 31:3847-3852.
28. Zhou, X. Y., F. Bordon, D. Sirot, M.-D. Kitzis, and L. Gutmann. 1994. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob. Agents Chemother. 38:1085-1089.